GFS Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

GFS Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-36,200	Closed	-$418K	–	155
2021 Q1	$418K	Sell	36,200 -35,000	-49%	-$404K	0.1%	106
2020 Q4	$687K	Hold	71,200	–	–	0.18%	78
2020 Q3	$642K	Hold	71,200	–	–	0.2%	74
2020 Q2	$878K	Hold	71,200	–	–	0.27%	63
2020 Q1	$639K	Buy	71,200 +700	+1%	+$6.28K	0.2%	72
2019 Q4	$691K	Buy	70,500 +1,000	+1%	+$9.8K	0.18%	79
2019 Q3	$478K	Hold	69,500	–	–	0.13%	90
2019 Q2	$641K	Buy	69,500 +51,000	+276%	+$470K	0.18%	79
2019 Q1	$290K	Sell	18,500 -2,500	-12%	-$39.2K	0.09%	98
2018 Q4	$324K	Sell	21,000 -650	-3%	-$10K	0.09%	97
2018 Q3	$466K	Hold	21,650	–	–	0.12%	96
2018 Q2	$527K	Sell	21,650 -2,000	-8%	-$48.7K	0.11%	108
2018 Q1	$404K	Sell	23,650 -5,000	-17%	-$85.4K	0.08%	119
2017 Q4	$543K	Sell	28,650 -10,650	-27%	-$202K	0.12%	108
2017 Q3	$692K	Buy	39,300 +4,550	+13%	+$80.1K	0.16%	95
2017 Q2	$1.15M	Sell	34,750 -750	-2%	-$24.9K	0.25%	74
2017 Q1	$1.14M	Sell	35,500 -18,826	-35%	-$604K	0.23%	78
2016 Q4	$1.97M	Buy	54,326 +16,750	+45%	+$607K	0.41%	55
2016 Q3	$1.73M	Buy	37,576 +15,600	+71%	+$718K	0.38%	66
2016 Q2	$1.1M	Sell	21,976 -10,075	-31%	-$506K	0.27%	78
2016 Q1	$1.72M	Sell	32,051 -255	-0.8%	-$13.6K	0.45%	56
2015 Q4	$2.12M	Sell	32,306 -1,250	-4%	-$82.1K	0.63%	46
2015 Q3	$1.9M	Sell	33,556 -5,516	-14%	-$312K	0.66%	50
2015 Q2	$2.31M	Buy	39,072 +2,411	+7%	+$142K	0.76%	46
2015 Q1	$2.28M	Buy	36,661 +19,366	+112%	+$1.21M	0.8%	41
2014 Q4	$995K	Buy	17,295 +995	+6%	+$57.2K	0.4%	66
2014 Q3	$876K	Sell	16,300 -100	-0.6%	-$5.37K	0.36%	69
2014 Q2	$860K	Sell	16,400 -1,450	-8%	-$76K	0.35%	71
2014 Q1	$943K	Hold	17,850	–	–	0.37%	67
2013 Q4	$715K	Buy	17,850 +1,200	+7%	+$48.1K	0.35%	63
2013 Q3	$629K	Hold	16,650	–	–	0.33%	69
2013 Q2	$653K	Buy	+16,650	New	+$653K	0.38%	67